Join our LinkedIn Group
and stay connected!

Mechanistic Insights
into Hepatotoxicity

Dealing with the
Blood-Brain Barrier

Corporate Sponsors

Sponsoring Organization

Lead Sponsoring Publications

Additional Media Partners

Final Days to Register!

Drug Discovery Innovation Summit

Targeting Pain with Novel Therapeutics

Successful Targeting of Alzheimer's Disease

Drug Safety Summit

Monitoring Cardiotoxicity and Drug Safety

New Tools for Detecting Nephrotoxicity

Early Assessments for Predicting Hepatotoxicity

Screening and Imaging Summit

Evaluating Novel Technologies for Cell Based Screening

Integrating in vivo Molecular Imaging in Drug Discovery and Development

Pharmacology Driven Assays for GPCRs and Ion Channels

Plenary Keynote Panel

Chris L. Waller, Ph.D., Senior Director, HealthCare Informatics, Medical Business Technology, Pfizer, Inc.	Thomas Bocan, Ph.D., Senior Director, Head of Pre- Clinical BioImaging Center, Pfizer Global Research and Development, Pfizer, Inc.
Gary Peltz, M.D., Ph.D., Professor, Anesthesia, Stanford University	Peggy Guzzie-Peck, Ph.D., DABT, Vice President, Head of Toxicology, Pathology & LAM, Johnson & Johnson, Pharma R&D
Marvin Bayne, Ph.D., Head of Discovery Technologies, Merck & Co.

Conference Short Courses - June 14 & 16

	Reactive Metabolites in Drug Discovery and Development-A Critical Examination of the Issues		Addressing Safety Concerns for Biological Drugs
	Animal Models of Pain: Progress and Challenges
	Translating Safety Biomarkers from the Lab to the Clinic		Mechanistic Insights into Cardiotoxicity
	Use of Stem Cells for Safety Screening		Mechanistic Insights into Hepatotoxicity
	Dealing with the Blood-Brain Barrier

Event Features

Plenary Keynote Panel
Interactive Breakout Discussion Groups
Access to Concurrent Tracks

Dedicated Exhibit Hall and Scientific Poster Viewing Hours
Over 500 International Participants
8 Short Courses